Literature DB >> 15101066

Pathologic fear conditioning and anorexia nervosa: on the search for novel paradigms.

Michael Strober1.   

Abstract

Although eating disorders have been the focus of an unprecedented explosion of clinical interest in recent years, the etiology of anorexia nervosa remains elusive. It is hypothesized that an underlying causative mechanism involves a propensity to extreme fear conditioning and greater than normal resistance to its extinction. Knowledge accrued from recent behavioral, genetic, and neuroanatomic research on anxiety may yield further insight into the pathogenesis of anorexia nervosa, which can be subjected to experimental validation using objective measures of classical fear conditioning and functional neuroimaging of brain structures mediating fear behavior. Copyright 2004 by Wiley Periodicals, Inc. Int J Eat Disord 35: 504-508, 2004.

Entities:  

Mesh:

Year:  2004        PMID: 15101066     DOI: 10.1002/eat.20029

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  38 in total

1.  What can cognitive neuroscience teach us about anorexia nervosa?

Authors:  Amelia Kidd; Joanna Steinglass
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

2.  Development of emotion acceptance behavior therapy for anorexia nervosa: a case series.

Authors:  Jennifer E Wildes; Marsha D Marcus
Journal:  Int J Eat Disord       Date:  2010-08-18       Impact factor: 4.861

Review 3.  Emotion-focused treatments for anorexia nervosa: a systematic review of the literature.

Authors:  Margarita Sala; Amy Heard; Elizabeth A Black
Journal:  Eat Weight Disord       Date:  2016-02-17       Impact factor: 4.652

4.  Selection of eating-disorder phenotypes for linkage analysis.

Authors:  Cynthia M Bulik; Silviu-Alin Bacanu; Kelly L Klump; Manfred M Fichter; Katherine A Halmi; Pamela Keel; Allan S Kaplan; James E Mitchell; Alessandro Rotondo; Michael Strober; Janet Treasure; D Blake Woodside; Vibhor A Sonpar; Weiting Xie; Andrew W Bergen; Wade H Berrettini; Walter H Kaye; Bernie Devlin
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

5.  Genetic association of recovery from eating disorders: the role of GABA receptor SNPs.

Authors:  Cinnamon S Bloss; Wade Berrettini; Andrew W Bergen; Pierre Magistretti; Vikas Duvvuri; Michael Strober; Harry Brandt; Steve Crawford; Scott Crow; Manfred M Fichter; Katherine A Halmi; Craig Johnson; Allan S Kaplan; Pamela Keel; Kelly L Klump; James Mitchell; Janet Treasure; D Blake Woodside; Enrica Marzola; Nicholas J Schork; Walter H Kaye
Journal:  Neuropsychopharmacology       Date:  2011-07-13       Impact factor: 7.853

6.  How does zinc supplementation benefit anorexia nervosa?

Authors:  C L Birmingham; S Gritzner
Journal:  Eat Weight Disord       Date:  2006-12       Impact factor: 4.652

Review 7.  Incorporating dimensions into the classification of eating disorders: three models and their implications for research and clinical practice.

Authors:  Jennifer E Wildes; Marsha D Marcus
Journal:  Int J Eat Disord       Date:  2013-07       Impact factor: 4.861

8.  Heterogeneity in Fear Processing across and within Anxiety, Eating, and Compulsive Disorders.

Authors:  Abby J Fyer; Franklin R Schneier; Helen Blair Simpson; Tse Hwei Choo; Stephanie Tacopina; Marcia B Kimeldorf; Joanna E Steinglass; Melanie Wall; B Timothy Walsh
Journal:  J Affect Disord       Date:  2020-07-22       Impact factor: 4.839

Review 9.  The enigmatic persistence of anorexia nervosa.

Authors:  B Timothy Walsh
Journal:  Am J Psychiatry       Date:  2013-05       Impact factor: 18.112

10.  Factors associated with recovery from anorexia nervosa.

Authors:  Stephanie Zerwas; Brian C Lund; Ann Von Holle; Laura M Thornton; Wade H Berrettini; Harry Brandt; Steven Crawford; Manfred M Fichter; Katherine A Halmi; Craig Johnson; Allan S Kaplan; Maria La Via; James Mitchell; Alessandro Rotondo; Michael Strober; D Blake Woodside; Walter H Kaye; Cynthia M Bulik
Journal:  J Psychiatr Res       Date:  2013-03-25       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.